Immunome
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Immunome 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About IMNM
Immunome, Inc. is a biopharmaceutical company, which engages in the discovery and development of antibody therapeutics products. It also focuses on oncology and infectious disease areas.
CEOClay B. Siegall
CEOClay B. Siegall
Employees177
Employees177
HeadquartersBothell, Washington
HeadquartersBothell, Washington
Founded2006
Founded2006
Employees177
Employees177
IMNM Key Statistics
Market cap2.31B
Market cap2.31B
Price-Earnings ratio-8.39
Price-Earnings ratio-8.39
Dividend yield—
Dividend yield—
Average volume1.24M
Average volume1.24M
High today$21.40
High today$21.40
Low today$19.81
Low today$19.81
Open price$21.23
Open price$21.23
Volume983.59K
Volume983.59K
52 Week high$27.65
52 Week high$27.65
52 Week low$5.15
52 Week low$5.15
Stock Snapshot
With a market cap of 2.31B, Immunome(IMNM) trades at $20.21. The stock has a price-to-earnings ratio of -8.39.
On 2026-03-16, Immunome(IMNM) stock moved within a range of $19.81 to $21.40. With shares now at $20.21, the stock is trading +2.0% above its intraday low and -5.6% below the session's peak.
Trading activity shows a volume of 983.59K, compared to an average daily volume of 1.24M.
The stock's 52-week range extends from a low of $5.15 to a high of $27.65.
The stock's 52-week range extends from a low of $5.15 to a high of $27.65.
Analyst ratings
100%
of 14 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own IMNM. This list is generated using Robinhood data, and it’s not a recommendation.